About this release
This release by Public Health Scotland (PHS) presents information on the number of take-home naloxone kits issued by the National Naloxone Programme (NNP) in Scotland. Figures are presented separately for kits issued from community outlets, kits issued in prisons at the point of liberation, kits dispensed via community prescription, and kits issued by Scottish Ambulance Service (SAS).
Accidental overdose is a common cause of death among users of heroin, morphine and similar drugs, which are referred to as opioids. Naloxone is a drug which reverses the effects of a potentially fatal overdose with these drugs.
During 2022/23 Quarter 4 (1 January 2023 to 31 March 2023):
- 7,468 Take-Home Naloxone (THN) kits were issued.
- 5,612 THN kits were issued by services based in the community.
- Community THN supplies included 2,045 kits issued by non-drug treatment services. Of these, 65% (1,325) were supplied by Scottish Families Affected by Alcohol & Drugs (SFAD).
- 515 kits were issued by prisons in Scotland.
- 1,080 kits were dispensed by community pharmacies.
- 231 THN kits were provided by the Scottish Ambulance Service.
- A total of 649 kits were supplied by peers (417 in the community and 232 in prisons).
At the end of 2022/23 Quarter 4, the 'reach' of the NNP (percentage of people at risk of opioid overdose who have been supplied with THN) was estimated to be 70.4%, an increase of 1.3 percentage points compared to 2022/23 Quarter 3 (69.1%).
The overall aim of Scotland’s NNP is to prevent fatal opioid overdoses. Administration of naloxone provides time for emergency services to arrive and for further treatment to be given. Following suitable training, THN kits are issued to people at risk of opioid overdose, their friends and family and service workers in order to help prevent overdose deaths. For more information on the background of the NNP and for a definition of 'reach', see Appendix 1 in the National Naloxone Programme Scotland Official Statistics report.
The next release of this publication will be 12 December 2023.
If you have an enquiry relating to this publication, please contact Gordon Hunt at email@example.com.
If you have a media enquiry relating to this publication, please contact the Communications and Engagement team.
Requesting other formats and reporting issues
If you require publications or documents in other formats, please email firstname.lastname@example.org.
To report any issues with a publication, please email email@example.com.